Triptonine B is primarily studied for its potential anti-cancer properties, particularly in inhibiting the growth of certain tumor cells. It has shown activity in inducing apoptosis and suppressing proliferation in cancer cell lines, making it a subject of interest in oncology research. Additionally, Triptonine B exhibits immunosuppressive effects, which may be useful in managing autoimmune diseases or preventing organ transplant rejection. Its biological activity also includes anti-inflammatory properties, suggesting possible applications in treating chronic inflammatory conditions. Due to its natural origin and complex structure, it serves as a lead compound for developing new therapeutic agents in drug discovery.